Parallel session abstracts
Cancer vaccines
- Telomerase-based immunotherapy of cancer
- DNA fusion gene vaccination, delivered with or without in vivo electroporation - a potent and safe strategy for inducing anti-tumor immune responses in prostate cancer
- IMP321 and weekly paclitaxel as first-line chemo-immunotherapy in metastatic breast cancer (MBC)
- Proffered paper: Use of nanomagnets to enhance monocyte delivery of gene therapy to tumours
- Proffered paper: Immunological targeting of the cancer phosphoproteome
- Proffered paper: Targeting inflammatory cytokines using adenoviruses- gene delivery of biological therapies in ovarian cancer
